×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Diffusion Pharma’s stockholders support merger with EIP Pharma
Pharmaceutical Technology
Diffusion Pharma's stockholders support merger with EIP Pharma. The merger will be finalised today, transforming the businesses into a single...
9 months ago
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
Yahoo Finance
Approximately 71% of Stockholders Voted in Favor of the TransactionDiffusion Announces 1-for-1.5 Reverse Stock SplitMerger on Track to Close...
9 months ago
CervoMed Announces Completion of Merger with EIP Pharma
PR Newswire
PRNewswire/ -- CervoMed Inc. (formerly known as Diffusion Pharmaceuticals Inc.) (NASDAQ: CRVO), now a clinical-stage company focused on...
9 months ago
EIP Pharma and Diffusion Pharmaceuticals Announce Merger Agreement to Create Leading CNS-focused Company ...
GlobeNewswire
Under the terms of the merger agreement subject to approval by EIP Pharma and Diffusion stockholders and satisfaction of other customary closing...
14 months ago
Can the Bass innovation diffusion model describe adsorption breakthrough curves of pharmaceutical contaminants?
ScienceDirect.com
Highlights. •. The Bass model is widely used in business innovation and marketing research. •. It can function as a breakthrough curve model. •.
10 months ago
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in ...
PR Newswire
PRNewswire/ -- EIP Pharma Inc. ("EIP Pharma" or the "Company"), a privately held clinical-stage company focused on developing treatments for...
9 months ago
Diffusion Pharmaceuticals seeks Wall Street investment while staying local
Charlottesville Tomorrow
Diffusion hopes to one day sell its glioblastoma drug to a major pharmaceutical company. Kalergis said the chance of a big payout from this sale...
83 months ago
EIP fuses with Diffusion to extend financial freeway past delivery of dementia data on ex-Vertex drug
Fierce Biotech
EIP Pharma has mapped out a financial freeway to the delivery of phase 2b on an ex-Vertex molecule. By merging with the floundering...
14 months ago
Diffusion to merge with EIP Pharma in all-stock deal
Seeking Alpha
Diffusion Pharmaceuticals (DFFN) is merging with privately held EIP Pharma in an all-stock deal to focus on neuro diseases. Read more here.
14 months ago
Acquisitions drive growth in pharma and biotech in the first half of 2023
The Pharma Letter
An analysis of recent mergers and acquisitions in the pharma sector.
11 months ago